Skip to main content
. 2017 Dec 23;9(3):4061–4073. doi: 10.18632/oncotarget.23664

Table 3. PIK3CA, PTEN and BMI in the WUSTL sequencing cohort.

Sample PIK3CA PTEN BMI HPV subtype
705973 p.E545K CN Loss 18.3 HPV 52
760832 p.E542K WT 18.8 HPV 16
724788 p.E39K WT 23.2 HPV 16, HPV 18
727879 p.E545K WT 23.2 HPV 16
740838 p.E545K WT 23.2 HPV 18
704786 p.E542Q WT 23.7 HPV 16
707755 WT CN Loss 24 HPV 16
734998 p.E545k, p.Q879* WT 24.4 HPV 31
733024 p.H1047R WT 25.2 HPV 16
703822 p.E545K WT 25.5 HPV 16
722396 p.E545K WT 25.5 HPV 16
710808 WT CN Loss 26 Many
704849 WT CN Loss 26.1 HPV 16
711380 WT CN Loss 26.6 Negative
736133 p.E545K WT 31.6 HPV 16
720170 WT p.R233* 31.8 Negative
704821 p.E81K WT 32.1 HPV 16
704956 p.E493K, p.E476Q, p.E494K WT 35 HPV 58
728723 p.E81K WT 35.7 HPV 16
720059 p.E545K WT 37.3 Negative
714694 p.E545.K WT 37.6 HPV 16
731976 WT p.R130Q 39.1 HPV 16
733384 WT CN Loss 39.7 HPV 33
714960 p.E542K WT 39.9 HPV 16
736462 p.E545K WT 43.2 HPV 16
711012 p.E545K WT 43.5 HPV 16
738147 p.C420R p.R130G, CN Loss 45 Negative
707913 WT CN Loss 47.1 HPV 16
755439 p.E545K WT 47.1 Many
746486 WT p.T319fs 56.5 Negative